ACC 2016

HOPE 3: Reducing LDL Improves Prognosis in Intermediate Risk Patients

In a large cohort of intermediate risk patients with no known CAD, treatment with low doses of...

ixCELL-DCM: Stem Cell Therapy Improves Outcomes in Patients with Heart Failure

Enhanced autologous bone marrow stem cell therapy improves clinical cardiac events in patients with heart failure and...

ACC 2016

65th Annual Scientific Session & Expo. April 2 - 4, 2016. Chicago. Find here the highlights from...